Professor Chan is currently the Associate Dean (Translation and Entrepreneurship) and Chairperson of Chemical Pathology at the Faculty of Medicine of the Chinese University of Hong Kong (CUHK). He is also the Chief of Service for Chemical Pathology at the Prince of Wales Hospital. He graduated from the Medical School of the University of Hong Kong and received training in internal medicine and gastroenterology. In 2001, he started his PhD training at CUHK.
Professor Chan’s main research interest focuses on the development of new diagnostic approaches based on circulating DNA analysis. He is a co-inventor of over 120 inventions in the fields of noninvasive prenatal testing and cancer detection, with an impressive 1,500 patents granted worldwide. He was named the “Top 20 Translational Researchers of 2020” by the world-renowned scientific journal Nature Biotechnology in 2021. Professor Chan has led a prospective trial involving over 20,000 subjects to investigate the use of liquid biopsy for the screening of early nasopharyngeal carcinoma (NPC). This work was published in the top journal the New England Journal of Medicine and was selected as that journal’s ten most notable articles in 2017. In recognition of his contributions, Professor Chan received the esteemed “Annual Achievement Award” from the Chinese Society of Clinical Oncology in 2018 and he has been endowed with the “Tony Mok Shu Kam Professorship in Medicine” by CUHK in 2024.